Home/Supreme Court/GlaxoSmithKline v. Classen Immunotherapies, Inc.

GlaxoSmithKline v. Classen Immunotherapies, Inc.

568 U.S. 1137, 133 S. Ct. 973, 184 L. Ed. 2d 751, 81 U.S.L.W. 3389, 2013 WL 141405, 2013 U.S. LEXIS 648
CourtSupreme Court of the United States
DecidedJanuary 14, 2013
DocketNo. 11-1078
StatusPublished

This text of 568 U.S. 1137 (GlaxoSmithKline v. Classen Immunotherapies, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
GlaxoSmithKline v. Classen Immunotherapies, Inc., 568 U.S. 1137, 133 S. Ct. 973, 184 L. Ed. 2d 751, 81 U.S.L.W. 3389, 2013 WL 141405, 2013 U.S. LEXIS 648 (2013).

Opinion

C. A. Fed. Cir. Certiorari denied.

Justice Alito took no part in the consideration or decision of this petition.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
568 U.S. 1137, 133 S. Ct. 973, 184 L. Ed. 2d 751, 81 U.S.L.W. 3389, 2013 WL 141405, 2013 U.S. LEXIS 648, Counsel Stack Legal Research, https://law.counselstack.com/opinion/glaxosmithkline-v-classen-immunotherapies-inc-scotus-2013.